As of June 19, 2015, the World Health Organization had received 1,338 notifications of laboratory-confirmed infection with Middle East respiratory syndrome coronavirus (MERS-CoV). Little is known about the course of or treatment for MERS-CoV in pregnant women. We report a fatal case of MERS-CoV in a pregnant woman administered combination ribavirin–peginterferon-α therapy.
All Keywords
【저자키워드】 Treatment, viruses, United Arab Emirates, MERS-CoV, Pregnancy, Fatal outcome, Surveillance, Middle East respiratory syndrome Coronavirus, influenza-like illness, WHO, UAE, World Health Organization, Abu Dhabi, 【초록키워드】 therapy, Infection, pregnant women, Pregnant woman, Combination, Middle East, respiratory syndrome coronavirus, laboratory-confirmed, Administered, Course, 【제목키워드】 respiratory, Middle East, Abu,
【저자키워드】 Treatment, viruses, United Arab Emirates, MERS-CoV, Pregnancy, Fatal outcome, Surveillance, Middle East respiratory syndrome Coronavirus, influenza-like illness, WHO, UAE, World Health Organization, Abu Dhabi, 【초록키워드】 therapy, Infection, pregnant women, Pregnant woman, Combination, Middle East, respiratory syndrome coronavirus, laboratory-confirmed, Administered, Course, 【제목키워드】 respiratory, Middle East, Abu,